BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

Biotechnology

Healthcare
$61.43 -0.18%

-$0.10 today

Market cap
$11.90B
Beta
0.24
P/E (TTM)
39.4
EPS (TTM)
$1.40
52W Low $49.26High $66.28

Volume 3.07M

Average 2.04M

BMRN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

BioMarin Pharmaceutical Inc.NASDAQ: BMRN

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin narrows to 80.0%

Gross margin was 80.0% in Q3 FY2026, down 2.0 pp from a year earlier. On a trailing-twelve-month basis it was 79.9%, down 1.4 pp year over year. Over 3 fiscal years it widened by 1.1 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
80.0%+0.4 pp QoQ
Last fiscal yearDec 2025
77.1%-2.5 pp YoY
LTMSep 2026
79.9%-1.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-2.0 pp——
1 year-2.5 pp——
3 years+1.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
77.1%
Year-over-year change
-2.5pp

Gross Margin vs competitors

How BMRN compares with its peers on the latest reported figures

  • BMRN's LTM Sep 2026 gross margin of 79.9% is the 9th highest of the 11 companies compared; the peer median is 84.6%.
  • Its year-over-year change of -1.4 pp is the 5th highest of 11, against a peer median of -1.6 pp.
  • Over three fiscal years its change of +1.1 pp compares with a peer median of -0.3 pp.
BMRN Competitors Peer median
Gross Margin for BMRN and competitors
Company Period LTM level YoY 3-year change
IONSIonis Pharmaceuticals, Inc.LTM Sep 202698.2% -0.6 pp+0.7 pp
BBIOBridgeBio Pharma, Inc.LTM Jun 202693.3% -2.8 pp-1.2 pp
ASNDAscendis Pharma A/SLTM Sep 202690.6% +3.8 pp+8.8 pp
PHARPharming Group N.V.LTM Mar 202687.3% -1.7 pp-3.6 pp
VRTXVertex Pharmaceuticals IncorporatedLTM Sep 202685.6% -0.7 pp-2.9 pp
RAREUltragenyx Pharmaceutical Inc.LTM Mar 202683.6% -1.6 pp-8.4 pp
INSMInsmed IncorporatedLTM Jun 202683.3% +7.6 pp+1.9 pp
PTCTPTC Therapeutics, Inc.LTM Jun 202682.1% -14.9 pp+2.2 pp
BMRNBioMarin Pharmaceutical Inc.LTM Sep 202679.9% -1.4 pp+1.1 pp
ALNYAlnylam Pharmaceuticals, Inc.LTM Jun 202679.7% -3.9 pp-2.0 pp
TVTXTravere Therapeutics, Inc.LTM Sep 202660.7% -37.0 pp+1.9 pp
Peer median (excluding BMRN) 84.6%-1.6 pp-0.3 pp

Competitors are the stored peer set for BMRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.85B2.1B2.42B2.85B3.22B
Cost of Revenue470.52M503.02M532.06M580.24M736.83M
Gross Profit1.38B1.59B1.89B2.27B2.48B
Gross Margin74.5%76.0%78.0%79.7%77.1%
Research & Development628.79M649.61M746.77M747.18M921.93M
Selling, General & Admin759.4M823.2M892.4M1.01B1.28B
Operating Expenses1.46B1.43B1.7B1.79B1.95B
Depreciation & Amortization108.04M101.97M104.39M96.43M79.56M
EBITDA47.43M265.36M306.77M650.53M572.94M
EBITDA Margin2.6%12.7%12.7%22.8%17.8%
Operating Income(82.34M)160.97M185.77M484.21M533.48M
Operating Margin-4.5%7.7%7.7%17.0%16.6%
Interest Income10.48M18.03M58.34M74.88M74.9M
Interest Expense15.34M15.97M17.34M12.67M10.9M
Other Income / Expenses6.99M(11.4M)2.79M57.55M(51M)
Income Before Tax(75.35M)149.58M188.56M541.76M482.48M
Pre-Tax Margin-4.1%7.1%7.8%19.0%15.0%
Income Tax Expense(11.27M)8.02M20.92M114.9M133.58M
Net Income(64.08M)141.56M167.65M426.86M348.9M
Net Margin-3.5%6.8%6.9%15.0%10.8%
EPS (Basic)(0.35)0.760.892.251.82
EPS (Diluted)(0.35)0.750.882.211.80
Weighted Avg Shares182.85M185.27M187.83M190.03M191.79M
Weighted Avg Shares (Diluted)182.85M188.96M191.6M196.71M197.39M

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

Intrinsic Alpha fair value

Locked

Current Price

$61.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.